<\/p>\n
Clinical Review of Smartphone Applications in Parkinson’s Disease – PubMed<\/a><\/p>\n Convention vs. innovation III: The promise of stem cell therapy in Parkinson’s disease remains bright (PSG debate 2024) – PubMed<\/a><\/p>\n Convention vs. innovation II: Genetic profiles should be a standard consideration in the assessment for deep brain stimulation candidacy for people with Parkinson’s disease (PSG debate 2024) – PubMed<\/a><\/p>\n \u00a0 \u00a0<\/span><\/p>\n Subtype I, comprised of 60 patients (~58.3%), was characterized by mild symptoms, both motor and non-motor.<\/p>\n < Abstract of\u00a0 <\/span>https:\/\/pubmed.ncbi.nlm.nih.gov\/34535682\/<\/a><\/p>\n \u00a0<\/span>https:\/\/pubmed.ncbi.nlm.nih.gov\/33545080\/<\/a>\u00a0 \u00a0 <\/span>< Stem cells<\/p>\n Freezing of gait in parkinsonian syndromes is a disabling motor block described by patients as having their feet stuck to the floor leading to difficulty in initiation of gait and increased risk for falls. Wearable assistive devices such as Google Glass\u2122 use visual and auditory cueing that may improve gait pattern in patients with freezing of gait. Augmented reality programs using wearable assistive devices are a home-based therapy, with the potential for reinforcing physical therapy techniques\u00a0<\/span><\/p>\n < https:\/\/pubmed.ncbi.nlm.nih.gov\/33216658\/<\/a> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/p>\n https:\/\/pubmed.ncbi.nlm.nih.gov\/37974260\/<\/a><\/p>\n https:\/\/pubmed.ncbi.nlm.nih.gov\/33463754\/<\/a><\/p>\n \u00a0<\/span>Current strategies to manage FOG include pharmacological interventions, physiotherapy, brain surgery (including deep brain stimulation\/DBS) and cueing.<\u00a0 \u00a0 <\/span>https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-023-01167<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Clinical Review of Smartphone Applications in Parkinson’s Disease – PubMed Convention vs. innovation III: The promise of stem cell therapy in Parkinson’s disease remains bright (PSG debate 2024) – PubMed Convention vs. innovation II: Genetic profiles should be a standard consideration in the assessment for deep brain stimulation candidacy for people with Parkinson’s disease … <\/p>\n